PubMed · 15775079
[Atherosclerosis and bisphosphonate].
Abstract
Bisphosphonates are widely used for the treatment of osteoporosis, hypercalcemia, Paget's disease, and osteolytic disease due to malignant tumor or its metastasis. Certain compounds of bisphosphonates have been shown to inhibit the development of experimental atherosclerosis without altering serum lipid profile. Recently, etidronate has been demonstrated to prevent the thickening of carotid arterial wall in diabetic patients associated with osteopenia. These findings may illuminate clinical application of bisphosphonates for the treatment of atherosclerosis and vascular calcification.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Atsushi Shioi. 2003. [Atherosclerosis and bisphosphonate].. https://pubmed.ncbi.nlm.nih.gov/15775079/
Cite the original work for its findings. Save a collection to share your selection of sources.